Literature DB >> 21475912

Microarray analysis of gene expression in the ovarian cancer cell line HO-8910 with silencing of the ZNF217 gene.

Guiqin Sun1, Jingxia Qin, Yuwen Qiu, Yunfei Gao, Yanhong Yu, Qinkai Deng, Mei Zhong.   

Abstract

Zinc-finger protein 217 (ZNF217), which is overexpressed during cancer progression, can promote tumor cell immortalization. To examine the function of ZNF217, a global expression profile was carried out using Affymetrix Gene Chip analysis with HG-U133 plus 2.0 arrays in the ovarian cancer cell line HO-8910 after silencing of the ZNF217 gene. The results were analyzed using the Gene Ontology program to investigate the functional network affected by ZNF217 in ovarian cancer cells. Changes in the mRNA expression of the affected genes were confirmed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR). The results showed that the ZNF217 gene is a key regulator of ovarian cancer, as the silencing of ZNF217 resulted in significant down-regulation by at least 8-fold of 164 genes in the HO-8910 cell line compared to non-silenced control cells. Among these down-regulated genes were ALOX15, CD1D, FXYD3, GAS6, KRT4, LIN7B, MMP-24, PDZK1, PEX6, PRSS8, SLC2A9, STRN and WFDC2. Down-regulation was confirmed by real-time RT-PCR after the silencing of ZNF217 (p<0.05). The results suggest that ZNF217 plays a central role in malignant processes in ovarian cancer.

Entities:  

Year:  2009        PMID: 21475912     DOI: 10.3892/mmr_00000183

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Roles of circ_0000135/miR-140-3p/PDZK1 network in cervical cancer.

Authors:  N Wang; Y Zheng; X Zhang; S W Xu; X H Li; Y L Meng; J Q Liu
Journal:  Clin Transl Oncol       Date:  2022-01-23       Impact factor: 3.405

Review 2.  The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value.

Authors:  Pascale A Cohen; Caterina F Donini; Nhan T Nguyen; Hubert Lincet; Julie A Vendrell
Journal:  Oncotarget       Date:  2015-12-08

3.  Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.

Authors:  Xingkang Jiang; Changwen Zhang; Shiyong Qi; Shanqi Guo; Yue Chen; E Du; Hongtuan Zhang; Xiaoming Wang; Ranlu Liu; Baomin Qiao; Kuo Yang; Zhihong Zhang; Yong Xu
Journal:  Oncotarget       Date:  2016-12-20

4.  Knocking down Sterol regulatory element binding protein 2 (SREBF2) inhibits the Serine Protease 8 (PRSS8) /sodium channel epithelial 1alpha subunit (SCNN1A) axis to reduce the cell proliferation, migration and epithelial-mesenchymal transformation of ovarian cancer.

Authors:  Chunyan Cai; Yumei Zhang; Xing Peng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer.

Authors:  Aeman Zahra; Qiduo Dong; Marcia Hall; Jeyarooban Jeyaneethi; Elisabete Silva; Emmanouil Karteris; Cristina Sisu
Journal:  J Clin Med       Date:  2021-05-05       Impact factor: 4.241

6.  Early detection biomarkers for ovarian cancer.

Authors:  Sreeja Sarojini; Ayala Tamir; Heejin Lim; Shihong Li; Shifang Zhang; Andre Goy; Andrew Pecora; K Stephen Suh
Journal:  J Oncol       Date:  2012-12-23       Impact factor: 4.375

7.  The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.

Authors:  Ayala Tamir; Anju Gangadharan; Sakshi Balwani; Takemi Tanaka; Ushma Patel; Ahmed Hassan; Stephanie Benke; Agnieszka Agas; Joseph D'Agostino; Dayoung Shin; Sunghoon Yoon; Andre Goy; Andrew Pecora; K Stephen Suh
Journal:  J Ovarian Res       Date:  2016-03-31       Impact factor: 4.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.